Notice Type
Notice Title

Notice of Reassessment of Registered Trade Name Products (Notice No. MPI 1167)

I, Maree Zinzley, Manager Approvals Operations, of the Ministry for Primary Industries (MPI), acting under delegated authority from the Director-General of MPI, give notice under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“Act”) that a decision has been made to reassess the following trade name products under section 29 of the Act:

Purpose of Reassessment

The purpose of the reassessment is to re-evaluate the approved label information, use patterns, and regulatory controls on the trade name product named below to ensure these details are consistent with the principles of prudent use for antibiotics and the prevention of antimicrobial resistance. As this product is approved for use in food-producing species, the New Zealand maximum residue levels (MRLs) associated with the active ingredient, and the product’s withholding periods, will also be re-evaluated during the reassessment.

The trade name product to be reassessed is:

Registration Number

Trade Name

Active Ingredients and Presentation


Draxxin Injectable Antibiotic Solution

Tulathromycin 100mg/mL in an aqueous solution for injection

Further information about the trade name product listed above, including its approved uses and target species, can be found on the ACVM Register. The register can be found at

Any person may make a written submission to the director-general concerning this application.

Each submission must state the trade name product(s) the submission pertains to.

Under sections 16 and 17 of the Act, a written submission:

  1. must state in full the reasons for making the submission; and
  2. may state any decision sought on that application; and
  3. must be received by the director-general no later than 30 working days after the date of notification in the New Zealand Gazette.

Under section 18 of the Act, a copy of every submission will be forwarded to the applicant for the applicant’s information.

If you wish to provide a submission, please email your submission to MPI encourages respondents to forward comments by email.

If you wish to forward a submission by post, the following address is:

  1. where submissions on this application are to be sent; and
  2. where requests for copies of the public information relating to the application can be sent; and
  3. where public information relating to the application can be viewed; and
  4. the director-general’s address for service:

ACVM Programmes and Appraisals, New Zealand Food Safety, Ministry for Primary Industries, PO Box 2526, Wellington 6140.

The applicant’s address for service is:

Zoetis New Zealand Limited, Level 4, 8 Mahuhu Crescent, Auckland Central Auckland 1010. Postal Address: PO Box 2094, Auckland 1140.

Dated at Wellington this 18th day of May 2020.

MAREE ZINZLEY, Manager Approvals Operations, Ministry for Primary Industries (acting under delegated authority).